The International Society for Cell & Gene Therapy (ISCT) has established a task force to address practical, ethical, and regulatory issues that arise from the use, and potential misuse, of expanded access within the cell and gene therapy (CGT) sector. Context Expanded access is… Read More
Automation is not just for high-throughput screening anymore. New devices and greater flexibility are transforming what’s possible throughout drug discovery and development. This article was written by Thomas Albanetti, AstraZeneca; Ryan Bernhardt, Biosero; Andrew Smith, AstraZeneca and Kevin Stewart, AstraZeneca for a 28-page DDW eBook, sponsored by Bio-Rad. Download the… Read More
DDW was delighted to work with CN Bio on an exclusive event that focused on novel approaches to human lung disease modelling. The free event took place on 29 March at 3pm. It covered: Accelerating the discovery of new therapeutics for treatment… Read More
Results from a pooled post-hoc analysis of the pivotal NAVIGATOR Phase III and PATHWAY Phase IIb trials showed AstraZeneca and Amgen’s Tezspire (tezepelumab) demonstrated reductions in the annualised asthma exacerbation rate (AAER) across biomarker subgroups of patients with severe asthma.1 According to the company, these findings support… Read More
New research published in Nature Communications by an international research team finds that people suffering from Covid-19 could have several different SARS-CoV-2 variants hidden away from the immune system in different parts of the body. What does this mean? The study’s authors say… Read More
BioTrinity 2022 will take place April 26-27, 2022 at 155 Bishopsgate in London, UK. The BioTrinity conference aims to catalyse growth and supports in-person engagement across the life sciences industry. The event will be attended by early-stage and emerging life sciences R&D companies, investors, large pharma,… Read More
For the last seven years, the LSX World Congress has bought together biotech, medtech and healthtech executives to connect with the capital, intelligence, innovation, and partners they need to grow their businesses. Back in-person for 2022, the 8th Congress takes place 10-11 May at 133 Houndsditch in London. … Read More
This most recent report by the Comptroller and Auditor General examines the rollout of the Covid-19 vaccination programme in England up to the end of October 2021, focusing on events up to the end of October 2021 and assessing whether the programme is well placed to meet its objectives… Read More
Domainex has purchased over £1 million worth of new Waters equipment to enhance its capabilities in analytical chemistry, bioanalytical sciences and in vitro absorbance, distribution, metabolism and excretion (ADME) assays. The company says the equipment will allow Domainex to increase its capacity and throughput, supporting its ongoing growth. … Read More
DDW was delighted to work with CN Bio on an exclusive event which focused on novel approaches to human lung disease modelling. The free event took place on 29 March at 3pm. It covered: Accelerating the discovery of new therapeutics for treatment… Read More
News round-up by DDW’s Megan Thomas for 28 February – 4 March, 2022 DDW has rounded up five news stories that showcase the international breakthroughs, approvals, alliances and research findings that pave the way for life-saving treatments in the future. 1. First live biotherapeutic approved to… Read More
DDW was delighted to work with CN Bio on an exclusive event which focused on novel approaches to human lung disease modelling. The free event took place on 29 March at 3pm. It covered: Accelerating the discovery of new therapeutics for treatment… Read More
In this article, Komal Kedia (Senior Scientist at Merck), Rena Zhang (Senior Scientist at Merck), Weixun Wang (Senior Scientist at Merck), Kevin Bateman (Scientific Associate VP at Merck) and Kelly Moser (Applications Manager at MOBILion Systems) show how ganglioside isomers with suspected roles in neurodegenerative diseases can be separated on… Read More
Lithuania is dedicating time and resources establishing itself as a life science and biotechnology hub of excellence. DDW’s Megan Thomas analyses four pillars of Lithuania’s growth strategy, which involves ensuring female scientists take leading roles in industry, focusing on investment, developing a strong talent pool as well establishing itself as a… Read More
Unlearn has entered into a multi-year collaboration with Merck to accelerate late-stage clinical trials with novel trial designs that include Digital Twins. Initially, the collaboration will focus on advancing the regulatory approval of candidates in Merck’s immunology pipeline, with the potential to expand into other therapeutic areas. … Read More
The MDI Biological Laboratory (MDIBL) has appointed James Strickland as Director of MDI Bioscience, a new initiative focused on using non-mammalian models in early drug discovery and development. Background Strickland brings experience in pharmaceutical development to his new position, in which he will leverage… Read More
